Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD276 anticorps (AA 100-300)

Cet anticorps anti-CD276 Monoclonal Souris (Clone B7H3-4479) (ABIN7864562) détecte spécifiquement CD276 dans IHC. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN7864562
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour CD276 anticorps (AA 100-300) (ABIN7864562)

Antigène

Voir toutes CD276 Anticorps
CD276

Reactivité

  • 118
  • 53
  • 15
  • 5
  • 5
  • 3
  • 2
  • 2
  • 1
Humain

Hôte

  • 64
  • 40
  • 21
  • 9
  • 1
  • 1
Souris

Clonalité

  • 90
  • 45
  • 1
Monoclonal

Conjugué

  • 75
  • 10
  • 7
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD276 est non-conjugé

Application

  • 66
  • 36
  • 32
  • 27
  • 19
  • 14
  • 13
  • 10
  • 9
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

B7H3-4479
  • Épitope

    • 15
    • 9
    • 8
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 100-300

    Fonction

    CD276 / B7-H3 Antibody

    Specificité

    T cell activation and immune function are regulated by the innate immune system through positive and negative costimulatory molecules. One such molecule, B7-H3 (B7-homolog 3, also designated B7RP-2) belongs to the B7 immunoglobulin superfamily. Soluble B7-H3 binds a putative receptor on activated T-cells that is distinct from CD28, CTLA-4, ICOS and PD-1. Widely expressed on nonlymphoid tissues, B7-H3 costimulates proliferation of both CD4+ and CD8+ T cells. The ability of B7-H3 to stimulate Th1 and cytotoxic-T cell responses suggest that it may have antitumor activity. B7-H3 interactions may play a role in regulating cell-mediated immune responses against cancer, implicating B7-H3 as a potential therapeutic tool.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment (around aa100-300) of human CD276 protein (exact sequence is proprietary)

    Isotype

    IgG1, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    CD276

    Autre désignation

    CD276

    Sujet

    4Ig B7 H3, B7 homolog 3, B7-H3, B7H3, B7RP-2, CD276, CD276 antigen, CD276 Molecule, Costimulatory molecule

    hepatocellular carcinoma or lung carcinoma.|Human tonsil|Placenta

    Poids moléculaire

    B7-H3 isoforms: 57/34/53/57 kDa, glycosylated B7-H3: 90-110 kDa

    ID gène

    80381, 77873

    UniProt

    Q5ZPR3

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!